This report combines two of Kalorama's latest research volumes DNA Sequencing and SNP Genotyping and Analysis Markets into one package, and includes a preface on the complementary/competitive use of SNP Analysis and whole-genome sequencing on topics and the impact of the results of GWAS on the market.
Related Reports:
Healthcare Reform: Winners and LosersMay 1, 2010 - KLI2625403 - $500.00
Lab Automation Markets, 2nd Edition (Systems, Key Companies, Forecasts and Trends)Mar 1, 2010 - KLI2601060 - $3,995.00
SNP Genotyping and Analysis Markets and the Future of Personalized MedicineFeb 1, 2010 - KLI2402105 - $3,995.00
DNA Sequencing Equipment and Services Markets, 2nd EditionAug 1, 2009 - KLI2122235 - $3,800.00
Pharmacodiagnostics and Personalized Medicine 2009 (Markets, Challenges, Forecasts and Key Players)Apr 1, 2009 - KLI2128157 - $3,500.00
Liquid Chromatography Markets (LC, HPLC and UHPLC)Mar 1, 2009 - KLI1430149 - $3,500.00
Key Genetic Technologies Market Research Bundle (SNPs, Gene Expression Profiling, DNA Sequencing and Analytical Chips)Nov 1, 2008 - KLI1689637 - $7,995.00
Effective Competitive Intelligence: A "How-To" Guide for Life Science CompaniesNov 1, 2008 - KLI1807610 - $499.00
SNP Genotyping and Analysis MarketsJun 1, 2008 - KLI1430117 - $3,995.00
Companion Diagnostics Markets (A Realistic Assessment of the Opportunities, Challenges, Key Players and Important Trends in 'Theranostics' and Personalized Medicine)Jun 1, 2008 - KLI1646599 - $2,995.00